Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Auspex Pharmaceuticals, Inc. (ASPX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Auspex Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1454189.
Total stock buying since 2014: $84,981,699.
Total stock sales since 2014: $139,532,265.
Total stock option exercises since 2014: $3,200,351.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2015 | 1,500,000 | $84,750,000 | 2,306,344 | $125,061,736 | 641,270 | $2,478,548 |
| 2014 | 11,846 | $231,699 | 391,969 | $14,470,529 | 188,123 | $721,803 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2015-03 | 0 | $0 | 3,000 | $239,436 | 3,000 | $2,700 |
| 2015-02 | 0 | $0 | 300,000 | $18,438,013 | 0 | $0 |
| 2015-01 | 1,500,000 | $84,750,000 | 2,003,344 | $106,384,287 | 638,270 | $2,475,848 |
| 2014-12 | 0 | $0 | 197,660 | $9,919,883 | 2,660 | $2,394 |
| 2014-10 | 0 | $0 | 57,109 | $1,519,231 | 120,302 | $466,650 |
| 2014-09 | 1,466 | $31,885 | 48,300 | $1,134,787 | 0 | $0 |
| 2014-08 | 0 | $0 | 51,700 | $1,130,383 | 0 | $0 |
| 2014-07 | 10,380 | $199,814 | 0 | $0 | 0 | $0 |
| 2014-05 | 0 | $0 | 37,200 | $766,245 | 65,161 | $252,759 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-16 | Stamler David A (Chief Medical Officer) | Sale | 3,000 | 79.81 | 239,436 |
| 2015-03-16 | Stamler David A (Chief Medical Officer) | Option Ex | 3,000 | .90 | 2,700 |
| 2015-02-13 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 41,833 | 62.98 | 2,634,767 |
| 2015-02-12 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 80,834 | 63.48 | 5,131,423 |
| 2015-02-11 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 53,100 | 61.84 | 3,283,704 |
| 2015-02-10 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 21,200 | 60.05 | 1,273,060 |
| 2015-02-09 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 9,854 | 59.00 | 581,386 |
| 2015-02-06 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 30,279 | 59.48 | 1,800,994 |
| 2015-02-05 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 12,900 | 59.51 | 767,679 |
| 2015-02-04 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 50,000 | 59.30 | 2,965,000 |
| 2015-01-28 | Zisson Alex (Director) | Sale | 730,000 | 53.11 | 38,770,300 |
| 2015-01-28 | Deerfield Private Design International Ii, L.p. | Buy | 1,500,000 | 56.50 | 84,750,000 |
| 2015-01-28 | Tmp Nominee Ii, Llc (10% Owner) | Sale | 730,000 | 53.11 | 38,770,300 |
| 2015-01-28 | Panorama Capital, L.p. (10% Owner) | Sale | 270,000 | 53.11 | 14,339,700 |
| 2015-01-28 | Ferguson Rodney A (Director) | Sale | 270,000 | 53.11 | 14,339,700 |
| 2015-01-08 | Zisson Alex (Director) | Option Ex | 319,135 | 3.88 | 1,237,924 |
| 2015-01-08 | Tmp Nominee Ii, Llc (10% Owner) | Option Ex | 319,135 | 3.88 | 1,237,924 |
| 2015-01-08 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 3,344 | 49.13 | 164,287 |
| 2014-12-22 | Stamler David A (Chief Medical Officer) | Sale | 2,660 | 53.60 | 142,583 |
| 2014-12-22 | Stamler David A (Chief Medical Officer) | Option Ex | 2,660 | .90 | 2,394 |
| 2014-12-18 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 195,000 | 50.14 | 9,777,300 |
| 2014-10-30 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 7,830 | 27.33 | 213,962 |
| 2014-10-29 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 11,170 | 27.02 | 301,846 |
| 2014-10-28 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 11,000 | 26.99 | 296,901 |
| 2014-10-27 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 3,500 | 27.11 | 94,899 |
| 2014-10-24 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 10,900 | 27.09 | 295,237 |
| 2014-10-23 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 5,600 | 26.73 | 149,716 |
| 2014-10-09 | Zisson Alex (Director) | Option Ex | 60,151 | 3.88 | 233,325 |
| 2014-10-09 | Tmp Nominee Ii, Llc (Director) | Option Ex | 60,151 | 3.88 | 233,325 |
| 2014-10-06 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 7,109 | 23.45 | 166,670 |
| 2014-09-19 | Proehl Gerald T (Director) | Buy | 1,466 | 21.75 | 31,885 |
| 2014-09-05 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 8,900 | 23.50 | 209,141 |
| 2014-09-04 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 16,700 | 24.05 | 401,668 |
| 2014-09-03 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 12,500 | 23.09 | 288,675 |
| 2014-09-02 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 10,200 | 23.07 | 235,303 |
| 2014-08-29 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 8,700 | 22.59 | 196,550 |
| 2014-08-28 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 12,200 | 22.24 | 271,352 |
| 2014-08-27 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 17,400 | 21.88 | 380,659 |
| 2014-08-26 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 6,300 | 21.35 | 134,517 |
| 2014-08-25 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 5,400 | 20.81 | 112,357 |
| 2014-08-22 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 1,700 | 20.56 | 34,948 |
| 2014-07-16 | Chowrira Bharat M (Chief Operating Officer) | Buy | 5,190 | 19.25 | 99,907 |
| 2014-07-16 | Greer R Scott (Director) | Buy | 5,190 | 19.25 | 99,907 |
| 2014-05-14 | Thomas, Mcnerney & Partners Ii, Llc (Director) | Option Ex | 65,161 | 3.88 | 252,759 |
| 2014-05-14 | Tmp Nominee Ii, Llc (10% Owner) | Sale | 24,800 | 20.60 | 510,830 |
Insider trading activities including stock purchases, stock sales, and option exercises of ASPX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Auspex Pharmaceuticals, Inc. (symbol ASPX, CIK number 1454189) see the Securities and Exchange Commission (SEC) website.